MRI in first episode psychosis
Dan Joyce publishes his debut blog on a recent paper in the British Journal of Psychiatry that considers the feasibility and clinical utility of magnetic resonance imaging in first-episode psychosis....
View Article#UnderstandingPsychosis?
Sameer Jauhar and Paul Morrison consider the revised Understanding Psychosis and Schizophrenia report from the British Psychological Society Division of Clinical Psychology, which includes updated...
View ArticleAntipsychotic combinations for schizophrenia: safe and effective?
Elena Marcus presents the findings of an updated Cochrane review on antipsychotic combinations for schizophrenia. The post Antipsychotic combinations for schizophrenia: safe and effective? appeared...
View ArticleAntidepressants for depression in schizophrenia: when good-enough evidence is...
Carmine Pariante is positive about a recent systematic review and meta-analysis of antidepressants for the treatment of depression in schizophrenia. The post Antidepressants for depression in...
View ArticleImproving health related quality of life for people with dementia in care homes
Hilary Shepherd writes her debut blog on a new paper from the WHELD cluster RCT, which looks at the impact of antipsychotic review and psychosocial intervention on health-related quality of life in...
View ArticleAntipsychotic effectiveness: the numbers don’t lie, check the scoreboard
Students and Teachers from the King’s College London PNoMH Distance Learning MSc summarise a major new meta-analysis that brings together the last 60 years of placebo-controlled antipsychotic drug...
View ArticlePerson-centred care for dementia: impact on quality of life, agitation and...
Hilary Shepherd reports on a recent paper from the WHELD trial on the impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people...
View ArticleImproving outcomes for people with first episode psychosis
Elwira Lubos summarises a recent review of reviews looking at the evidence for improving outcomes in first-episode psychosis. The post Improving outcomes for people with first episode psychosis...
View ArticleUnderstanding the genetics of antipsychotic treatment response
Marcus Munafo looks at a Chinese genome-wide association study that claims to have identified some of the genes associated with response to antipsychotic treatment. The post Understanding the genetics...
View ArticlePolypharmacy for major depression: is practice evidence-based?
Jessica Bone reports on a recent cross-sectional study that looks at the clinical correlates of augmentation/combination treatment strategies in major depressive disorder. The post Polypharmacy for...
View ArticleSexual function matters to people living with serious mental illness
Rudiger Pittrof and Elana Covshoff from SHRINE (Sexual and Reproductive Health Rights, Inclusion and Empowerment) explore a recent review, which looks at the impact of severe mental disorders and...
View ArticleHow should we redirect research on psychiatric drugs? #PsychDrugDebate
Alison Faulkner dissects the new McPin Foundation Talking Point Paper by Jasna Russo entitled: Through the eyes of the observed: re-directing research on psychiatric drugs. Follow #PsychDrugDebate...
View Article“Where I End And You Begin”: A personal commentary on Russo’s ‘Through the...
Sarah Carr shares her own experiences of psychiatric medication and provides a critical reading of Jasna Russo’s new #PsychDrugDebate paper: ‘Through the eyes of the observed: re-directing the research...
View ArticleLow dose Amisulpride for very late onset schizophrenia-like psychosis: the...
Elwira Lubos summarises the recent ATLAS RCT of antipsychotic treatment for very late-onset schizophrenia-like psychosis, which provides evidence for the effectiveness of a very low dose of Amisulpride...
View ArticleIs Cannabidiol (CBD) an effective antipsychotic?
Luke Sheridan Rains publishes his debut blog on a recent multicentre RCT of Cannabidiol (CBD) as an adjunctive therapy for people with schizophrenia, which suggests that CBD had a beneficial, but...
View ArticleMedical cannabis for mental illness: current use is not supported by research...
As we prepare for our Cannabis #MHQT event on Wed 26 Sep, Luke Sheridan Rains dissects a narrative review that asks: Is cannabis treatment for anxiety, mood, and related disorders ready for prime time?...
View ArticleBehavioural and psychological symptoms of dementia: GPs’ perspective on...
Marie Crabbe presents the findings of a mixed-methods systematic review, which looks at General Practitioners’ knowledge, attitudes and experiences of managing behavioural and psychological symptoms of...
View ArticlePreventing psychosis: no one intervention is better than the rest
A group of UCL Mental Health Masters students summarise a recent network meta-analysis that highlights a lack of evidence about specific interventions for preventing psychosis. The post Preventing...
View ArticleGenetics of depression: understanding risk and improving treatment
Douglas Levinson on a genome-wide meta-analysis of depression in 807,553 individuals, which identifies 102 independent variants relating to the genetics of depression. The post Genetics of depression:...
View ArticleLifestyle training for schizophrenia: STEPWISE fails to make a difference
Ben Janaway writes his debut elf blog on the STEPWISE RCT which is out today in the British Journal of Psychiatry: Structured lifestyle education for people with schizophrenia, schizoaffective disorder...
View Article